CDEK
← All drugs Report issue

dc vaccine

Cell therapyexperimental

Clinical trial activity

22 trials · 29 clinical orgs · 0 marketing orgs

Phase 1
14
Phase 2
8
Phase 3
1
Phase 4
0

Earliest trial started Jun 1, 2005 (NCT00327496)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2025

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • dc vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07146672Phase 1/Phase 2 (Phase 2)Jul 31, 2025Shanghai Cell Therapy Group Co.,Ltd
NCT06805656N/AApr 1, 2025Conselho Nacional de Desenvolvimento Científico e Tecnológico, Federal University of Sao Paulo
NCT06799026Phase 1Jan 31, 2025Harvard University, Pfizer
NCT06749925Phase 3Jan 31, 2025University of Sao Paulo
NCT06682117N/ANov 5, 2024Fudan University
NCT06522919Phase 2Sep 1, 2024Istituto Nazionale per lo Studio e la Cura dei Tumori
NCT06253234Phase 1Feb 2, 2024Capital Medical University, Guangdong Zhongsheng Pharmaceutical Co., Ltd.
NCT06036355Early Phase 1 (Phase 1)Sep 30, 2023Shanghai Cell Therapy Group Co.,Ltd
NCT05767684Phase 1Jun 1, 2023Government of Taiwan, Kaohsiung Medical University, National Cheng Kung University
NCT05809752Phase 1Mar 28, 2023Department of Defense, University of South Florida
NCT05773859Phase 1/Phase 2 (Phase 2)Mar 17, 2023Radboud University
NCT05321940Phase 1Jan 31, 2023University of Miami
NCT05000801N/AJul 1, 2021People's Liberation Army of China
NCT04999943Phase 1Jul 1, 2021People's Liberation Army of China
NCT04567069Phase 1/Phase 2 (Phase 2)Sep 30, 2020Shandong University, Shanghai Sunstem Biotechnology Co., Ltd.
NCT03730948Phase 1Mar 12, 2019University of Pennsylvania
NCT02543749Phase 1/Phase 2 (Phase 2)Jul 1, 2014Humboldt University
NCT01671592Phase 1Jan 1, 2013National Cancer Institute (NCI), University of Pittsburgh
NCT01686334Phase 2Oct 1, 2012Clinique Charcot, University of Antwerp
NCT00978913Phase 1Sep 1, 2009University of Copenhagen
Showing 20 of 22 trials
Page 1 / 2

Organizations

Research & Development (29)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
People's Liberation Army of ChinaGovernment2222021
Shanghai Cell Therapy Group Co.,LtdFor profit2222023
Baylor UniversityAcademic/Hospital1112008
Capital Medical UniversityAcademic/Hospital1112024
Clinique CharcotAcademic/Hospital1112012
Conselho Nacional de Desenvolvimento Científico e TecnológicoGovernment1012025
Department of DefenseGovernment1012023
Federal University of Sao PauloAcademic/Hospital1112025
Fudan UniversityAcademic/Hospital1112024
Government of TaiwanGovernment1112023
Guangdong Zhongsheng Pharmaceutical Co., Ltd.For profit1012024
Harvard UniversityAcademic/Hospital1112025
Humboldt UniversityAcademic/Hospital1112014
Istituto Nazionale per lo Studio e la Cura dei TumoriAcademic/Hospital1112024
Kaohsiung Medical UniversityAcademic/Hospital1012023
Mackay Medical CollegeAcademic/Hospital1112005
National Cancer Institute (NCI)Government1012013
National Cheng Kung UniversityAcademic/Hospital1012023
PfizerFor profit1012025
Radboud UniversityAcademic/Hospital1112023
29 organizations
Page 1 / 2